SCHEMBL5334064

SCHEMBL5334064

CCOC(=O)C1=C(C)NC2=C(C(=O)CC(c3ccc(OC)cc3)C2)C1c1ccccc1OC(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.58
ALDH1A1 P00352 9/20 0.58
HPGD P15428 6/20 0.58
HSD17B10 Q99714 6/20 0.58
TP53 P04637 3/20 0.58
CASP1 P29466 3/20 0.58
CASP7 P55210 3/20 0.58
USP2 O75604 2/20 0.58
ALOX15 P16050 2/20 0.58
GLA P06280 2/20 0.58
MAPK1 P28482 2/20 0.56
RAB9A P51151 1/20 0.56
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
POLB P06746 4/20 0.51
LMNA P02545 2/20 0.51
AGTR1 P30556 1/20 0.51
GAA P10253 4/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5479523 0.94 KDM4E (0.56) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL5331923 0.92 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL5330608 0.91 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL3324919 0.86 ALDH1A1 (0.57) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL5330819 0.85 KDM4E (0.57) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL5335113 0.85 GPBAR1 (0.64) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL3323110 0.85 KDM4E (0.64) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL5476328 0.85 ALDH1A1 (0.57) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL5310139 0.85 ALDH1A1 (0.57) KDM4EALDH1A1HPGDHSD17B10TP53
SCHEMBL5334201 0.84 ALDH1A1 (0.54) KDM4EALDH1A1HPGDHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
WO-2007051062-A2 SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112015-A1 Substituted dihydropyridines and methods of use C3AR1, C5AR1, C5AR2 KDM4E 4033/4885ALDH1A1 1488/4885HPGD 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.